Table 1. The essential characteristics of the studies we included.
First author | Year | Ethnicity | Genotyping method | Diagnostic criteria of COPD | Resources |
Sample size |
Mean age |
Smoking history (pack-years) |
Gender distribution (male/female) |
Mean FEV1 (L) |
Mean FEV1/FVC (%) |
HWE | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cases | Controls | Cases | Controls | Cases | Controls | Cases | Controls | Cases | Controls | Cases | Controls | Cases | Controls | ||||||||||||
Lu (22) | 2004 | Asian | PCR-RFLP | Guidelines of COPD diagnosis and treatment [1997] | local hospital | Healthy smokers (≥400 pack-years) with no history of COPD and a normal spirometry (age ≥50 years) | 69 | 52 | 67.1±7.4 | 64.9±8.6 | 820.4±429.7 | 690.6±353.5 | NG | NG | NG | NG | NG | NG | 0.45 | ||||||
Huang (28) | 2007 | Asian | PCR-RFLP | Guidelines of COPD diagnosis and treatment [2002] | local hospital | Healthy individuals with a normal spirometry | 75 | 69 | 60±6 | 60±6 | 37±4 | 37±4 | 75/0 | 69/0 | NG | NG | 60±4 | 86±3 | 0.095 | ||||||
Shen (25) | 2010 | Asian | PCR-RFLP | Guidelines of The American Thoracic | local hospital | Healthy adults with no history of COPD and spirometry show FEV1 >85% pred and FEV1/FVC >75% | 100 | 100 | 62.3±9.7 | 60.9±8.6 | 123.5±29.7 | 25.6±13.3 | 72/28 | 66/34 | 1.28±0.43 | 3.57±0.65 | 43.5±12.8 | 92.8±5.8 | 0.12 | ||||||
Society | |||||||||||||||||||||||||
Laufs (29) | 2004 | Caucasian | PCR-RFLP | Guidelines of The American Thoracic | local hospital | Healthy volunteers from the same area (mostly non-smokers) | 102 | 183 | 71.7 | 42.9 | 38 | NG | 42/60 | 105/78 | NG | NG | NG | NG | 0.84 | ||||||
Society | |||||||||||||||||||||||||
Ito (24) | 2004 | Asian | PCR-RFLP | Guidelines of The American Thoracic | local hospital | Healthy smokers (>20 pack-years) with no history of COPD and a normal spirometry | 103 | 88 | 67.4±7.8 | 60.8±12.0 | 58.3±29.1 | 41.1±22.2 | Apr-99 | 72/16 | 1.18±0.49 | 2.66±0.86 | 45.8±10.4 | 80.1±7.8 | 0.016 | ||||||
Society | |||||||||||||||||||||||||
Ishii (23) | 2001 | Asian | PCR-RFLP | Guidelines of The American Thoracic | local hospital | Healthy, anonymous, ethnically matched volunteers | 63 | 82 | 68.3±9.9 | NG | 102.2±40.4 | NG | Mar-60 | 42/40 | NG | NG | 44.3±12.7 | NG | 0.31 | ||||||
Society | |||||||||||||||||||||||||
Horne (27) | 1990 | Caucasian | Isoelectric focusing electrophoresis | Chronic bronchitis and emphysema | local hospital | local residents with similar ethnic origins | 104 | 413 | NG | NG | NG | NG | NG | NG | NG | NG | NG | NG | 0.34 | ||||||
Wood (21) | 2011 | Caucasian | PCR-RFLP | FEV1/FVC<0.7 and post-bronchodilator FEV1<80% predicted | the UK national registry | Healthy, anonymous, geographically matched individuals | 93 | 351 | NG | NG | NG | NG | NG | NG | NG | NG | 36 | NG | 0.45 | ||||||
Jung (34) | 2014 | Asian | PCR-RFLP | post-bronchodilator FEV1/FVC<0.7 | KOLD Cohort | Healthy smokers with a normal spirometry | 203 | 157 | 67 | 53 | 46.0±23.4 | 30.7±17.4 | 199/4 | 148/9 | 1.42±0.49 | 3.17±0.59 | 47.5±10.9 | 78.3±5.1 | 0.12 |
COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; HWE, Hardy-Weinberg equilibrium; PCR-RFLP, polymerase chain reaction-restriction fragment length polymorphism; KOLD, Korean obstructive lung disease.